ChAdOx2 LungVax clinical trials

A clinical trial testing vaccines designed to prevent lung cancer in people at risk of recurrent or new lung cancer

This study is testing a new vaccine (ChAdOx2 LungVax) designed to prevent lung cancer. It's for people who have recently had early lung cancer removed or are at high risk through an NHS screening programme. Researchers want to see if the vaccine is safe and effective.